Kite Pharma, Inc.
$34.1M 2,852 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Braintree Laboratories, Inc.
Braintree Laboratories, Inc. reported $33,946,527.64 across General Payments, Research, and Ownership to 5,369 physicians and teaching hospitals across 8,836 transactions.
- $33.9M
- All-tracks total
- 8,836
- Transactions
- 5,369
- Recipients
- −$88.9K
- General Payments vs PY2023
Braintree Laboratories, Inc. reported $33,946,527.64 across all CMS Open Payments tracks (General + Research + Ownership) to 5,369 physicians and teaching hospitals in Program Year 2024 - ranking #63 of 1,925 reporting manufacturers (0.2% of the all-tracks industry total); General Payments alone were $652,028.36, averaging $6.3K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer braintree-laboratories-inc Braintree Laboratories, Inc.
$33.9M · #63/1,925 · 0.2% industry · PY2024
- TOT $33.9M
- RANK #63
- SHARE 0.2%
- TXN 8,836
- RCP 5,369
- CAT 6
- GEN $652.0K
- ΔGEN −$88.9K
- TOP1 34.4%
- PY 2024
Volume peers
Nearest volume peer: Kite Pharma, Inc. ($34.1M)
Braintree Laboratories, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Braintree Laboratories, Inc.'s CMS-reported General Payments decreased by $88.9K (−12.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: BRAINTREE LABORATORIES, INC.PY2023: BRAINTREE LABORATORIES, INC.PY2024: Braintree Laboratories, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $740,931.65
- PY2024
- $652,028.36
What the Data Shows for Braintree Laboratories, Inc.
Rank #63 of 1,925 companies in CMS Open Payments for 2024 belongs to Braintree Laboratories, Inc., which reported $33,946,527.64 across 8,836 transactions to 5,369 recipients - representing 0.2% of all industry payments reported nationwide for the year. Averages work out to $3.8K per transaction and $6.3K per recipient.
The 6-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Royalty or License" at $382.1K, accounting for 58.6% of this company's General Payments and 12 transactions.
General Payment Breakdown by Type
Braintree Laboratories, Inc. made 6 types of general payments. "Royalty or License" is the largest category at $382.1K, 58.6% of General Payments.
Braintree Laboratories, Inc. reports 6 general-payment categories - the top three are Royalty or License (58.6%), Consulting Fee (22.2%), and Food and Beverage (16.3%). The remaining 3 categories make up 2.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Braintree Laboratories, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $382.1K | 12 | 58.6% |
| Consulting Fee | $144.9K | 21 | 22.2% |
| Food and Beverage | $106.6K | 5,140 | 16.3% |
| Gift | $12.9K | 178 | 2.0% |
| Grant | $5.5K | 3 | 0.8% |
| Education | $80.85 | 15 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $515,137.03 (79.0%) of $652,028.36 in this company's General Payments records across 3,621 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Braintree Laboratories, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
John Fordtran
$224,157.00 across 8 reported transactions
- 2
Glenn Davis
$157,911.49 across 4 reported transactions
- 3
Jack Dipalma
$124,029.21 across 12 reported transactions
- 4
Francis Farraye
$5,000.00 across 1 reported transactions
- 5
Daniel John Pambianco
$4,039.33 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Braintree Laboratories, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Braintree Laboratories, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Braintree Laboratories, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Mirati Therapeutics, Inc.
$33.7M 4,888 recipients
Compare payment profiles
Alexion Pharmaceuticals, Inc.
$34.7M 48,499 recipients
Compare payment profiles
SN Holdings, LLC
$32.8M 35 recipients
Compare payment profiles
Allerderm Laboratories
$32.7M 5 recipients
Compare payment profiles
Janssen Biotech, Inc.
$31.5M 298,174 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.